Nutex Health Inc. (NUTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 28.24M |
| Enterprise value | 270.63M |
| Trailing P/E | 0.95 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.10 |
| Price/book (mrq) | 0.45 |
| Enterprise value/revenue | 1.05 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.56 |
| 52-week change 3 | -91.44% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 7.0800 |
| 52-week low 3 | 0.5000 |
| 50-day moving average 3 | 0.6486 |
| 200-day moving average 3 | 2.0899 |
Share statistics
| Avg vol (3-month) 3 | 305.76k |
| Avg vol (10-day) 3 | 190.64k |
| Shares outstanding 5 | 49.72M |
| Implied shares outstanding 6 | 49.72M |
| Float 8 | 27.92M |
| % held by insiders 1 | 42.70% |
| % held by institutions 1 | 9.95% |
| Shares short (15 May 2024) 4 | 325.39k |
| Short ratio (15 May 2024) 4 | 0.82 |
| Short % of float (15 May 2024) 4 | 1.06% |
| Short % of shares outstanding (15 May 2024) 4 | 0.65% |
| Shares short (prior month 15 Apr 2024) 4 | 178.8k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 01 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 10 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -15.85% |
| Operating margin (ttm) | 2.15% |
Management effectiveness
| Return on assets (ttm) | 0.66% |
| Return on equity (ttm) | -39.09% |
Income statement
| Revenue (ttm) | 258.77M |
| Revenue per share (ttm) | 5.70 |
| Quarterly revenue growth (yoy) | 19.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.38M |
| Net income avi to common (ttm) | -41M |
| Diluted EPS (ttm) | 0.6000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 30.01M |
| Total cash per share (mrq) | 0.6 |
| Total debt (mrq) | 272.39M |
| Total debt/equity (mrq) | 340.44% |
| Current ratio (mrq) | 1.68 |
| Book value per share (mrq) | 1.27 |
Cash flow statement
| Operating cash flow (ttm) | 3.26M |
| Levered free cash flow (ttm) | 3.96M |
© 2024 Yahoo. All rights reserved.